Mineralys Therapeutics (MLYS) Institutional Ownership → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free MLYS Stock Alerts $13.00 -0.15 (-1.14%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Mineralys Therapeutics (NASDAQ:MLYS)CurrentInstitutional OwnershipPercentage84.46%Number ofInstitutional Buyers(last 12 months)31TotalInstitutional Inflows(last 12 months)$173.86MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$3.94M Get MLYS Insider Trade Alerts Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MLYS Institutional Buying and Selling by Quarter Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Mineralys Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 RA Capital Management L.P.4,850,984$62.63M0.8%+52.6%9.770% 5/16/2024 California State Teachers Retirement System1,953$25K0.0%-38.9%0.004% 5/15/2024 Bellevue Group AG9,200$119K0.0%N/A0.019% 5/15/2024 Affinity Asset Advisors LLC327,959$4.23M0.5%N/A0.661% 5/14/2024 EntryPoint Capital LLC4,632$60K0.1%-30.4%0.009% 5/14/2024 SR One Capital Management LP2,016,822$26.04M7.2%+12.4%4.062% Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/10/2024 Vanguard Group Inc.982,932$12.69M0.0%+0.5%1.980% 4/29/2024 China Universal Asset Management Co. Ltd.7,931$102K0.0%+67.0%0.016% 3/22/2024 PNC Financial Services Group Inc.4,122$35K0.0%+17,821.7%0.010% 2/14/2024 Catalys Pacific LLC9,194,579$79.07M74.1%N/A22.371% 2/14/2024 Pale Fire Capital SE34,743$299K0.0%N/A0.085% 2/14/2024 Sectoral Asset Management Inc.605,606$5.21M2.2%-28.0%1.473% 2/13/2024 Tower Research Capital LLC TRC 2,879$25K0.0%-71.4%0.007% 2/13/2024 NEOS Investment Management LLC23,973$206K0.0%N/A0.058% 2/9/2024 Franklin Resources Inc.699,467$6.02M0.0%+55.4%1.702% 2/9/2024 CreativeOne Wealth LLC10,750$92K0.0%N/A0.026% 2/7/2024 Jump Financial LLC20,500$176K0.0%-37.3%0.050% 2/5/2024 Russell Investments Group Ltd.5,779$50K0.0%-43.2%0.014% 2/1/2024 CWM LLC5,891$51K0.0%+120.0%0.014% 1/31/2024 Federated Hermes Inc.20,032$172K0.0%-10.1%0.049% 1/30/2024 Cornercap Investment Counsel Inc.22,209$191K0.0%N/A0.054% 1/24/2024 China Universal Asset Management Co. Ltd.4,750$41K0.0%N/A0.012% 1/16/2024 Raymond James Financial Services Advisors Inc.14,611$126K0.0%-64.0%0.036% 1/12/2024 SG Americas Securities LLC10,093$87K0.0%N/A0.025% 11/15/2023 Sectoral Asset Management Inc.840,759$8.00M1.6%+36.8%2.046% 11/15/2023 Laurion Capital Management LP969,978$9.22M0.1%+42.6%2.360% 11/14/2023 Braidwell LP2,023,900$19.25M0.6%+267.8%4.924% 11/14/2023 Schonfeld Strategic Advisors LLC192,362$1.83M0.0%+64.3%0.468% 11/13/2023CHI Advisors LLC568,379$5.41M1.6%N/A1.383% 11/13/2023 Federated Hermes Inc.22,293$212K0.0%+8.3%0.054% 11/13/2023 FMR LLC1,188,653$11.30M0.0%+62.6%2.892% 11/7/2023 Jump Financial LLC32,700$311K0.0%N/A0.080% 10/24/2023 Raymond James Financial Services Advisors Inc.40,578$386K0.0%N/A0.099% 10/11/2023 CWM LLC2,678$25K0.0%N/A0.007% 9/21/2023 Barclays PLC2,778$47K0.0%-77.8%0.007% 8/15/2023 Sphera Funds Management LTD.405,400$6.91M1.1%+19.6%0.992% 8/14/2023 Great Point Partners LLC546,059$9.31M1.8%-12.0%1.336% 8/14/2023 Driehaus Capital Management LLC499,983$8.53M0.1%+10.4%1.224% 8/11/2023 Panagora Asset Management Inc.23,016$392K0.0%N/A0.056% 8/11/2023 Sectoral Asset Management Inc.614,713$10.48M1.7%+0.2%1.504% [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now.8/11/2023 ExodusPoint Capital Management LP193,525$3.30M0.0%+6.7%0.474% 8/10/2023 Letko Brosseau & Associates Inc.11,400$194K0.0%N/A0.028% 8/4/2023 American International Group Inc.6,717$115K0.0%+15.0%0.016% 8/2/2023 Bank of Montreal Can101,724$1.51M0.0%N/A0.249% 5/19/2023 SR One Capital Management LP1,794,600$28.10M9.5%N/A4.392% 5/16/2023 Great Point Partners LLC620,326$9.71M1.9%N/A1.518% 5/16/2023 Ghisallo Capital Management LLC10,000$157K0.0%N/A0.024% 5/15/2023 Affinity Asset Advisors LLC62,500$979K0.3%N/A0.153% 5/15/2023 Logos Global Management LP300,000$4.70M0.7%N/A0.734% 5/15/2023 RTW Investments LP922,100$14.44M0.3%N/A2.257% 5/12/2023 Sectoral Asset Management Inc.613,233$9.60M1.8%N/A1.501% 5/11/2023 ExodusPoint Capital Management LP181,312$2.84M0.0%N/A0.444% 5/11/2023 American Century Companies Inc.417,903$6.53M0.0%N/A1.023% 5/5/2023 Monashee Investment Management LLC110,000$1.72M0.5%N/A0.269% 4/27/2023 Strs Ohio2,500$39K0.0%N/A0.006% (Data available from 1/1/2016 forward) MLYS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MLYS shares? During the previous two years, 43 institutional investors and hedge funds held shares of Mineralys Therapeutics. The most heavily invested institutionals were Catalys Pacific LLC ($79.07M), RA Capital Management L.P. ($62.63M), SR One Capital Management LP ($26.04M), Braidwell LP ($19.25M), RTW Investments LP ($14.44M), Vanguard Group Inc. ($12.69M), and FMR LLC ($11.30M).Learn more on MLYS's institutional investors. What percentage of Mineralys Therapeutics stock is owned by institutional investors? 84.46% of Mineralys Therapeutics stock is owned by institutional investors. Learn more on MLYS's institutional investor holdings. Which institutional investors have been buying Mineralys Therapeutics stock? Of the 38 institutional investors that purchased Mineralys Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Catalys Pacific LLC ($9.19M), SR One Capital Management LP ($2.02M), RA Capital Management L.P. ($1.67M), Braidwell LP ($1.47M), RTW Investments LP ($922.10K), Sectoral Asset Management Inc. ($840.76K), and Great Point Partners LLC ($620.33K). How much institutional buying is happening at Mineralys Therapeutics? Institutional investors have bought a total of 20,265,039 shares in the last 24 months. This purchase volume represents approximately $224.59M in transactions. Which Mineralys Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Mineralys Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Sectoral Asset Management Inc. ($235.15K), Great Point Partners LLC ($74.27K), Raymond James Financial Services Advisors Inc. ($25.97K), Jump Financial LLC ($12.20K), Barclays PLC ($9.76K), Tower Research Capital LLC TRC ($7.18K), and Russell Investments Group Ltd. ($4.40K). How much institutional selling is happening at Mineralys Therapeutics? Institutional investors have sold a total of 374,452 shares in the last 24 months. This volume of shares sold represents approximately $3.94M in transactions. Related Companies: PHAR Institutional Ownership LYEL Institutional Ownership ZYME Institutional Ownership SVRA Institutional Ownership SLN Institutional Ownership CALT Institutional Ownership GHRS Institutional Ownership AVBP Institutional Ownership ORIC Institutional Ownership PHAT Institutional Ownership This page (NASDAQ:MLYS) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.